Cryoport, Inc. is a leader in temperature-controlled supply chain solutions for the life sciences industry. Through its industry-leading portfolio of companies – Cryoport Systems, MVE Biological Solutions, CRYOPDP, and CRYOGENE – the company provides an ever-evolving platform of critical products and solutions including advanced packaging, informatics, specialty logistics services, biostorage services, and cryogenic equipment. Cryoport, Inc. serves the biopharmaceutical/pharmaceutical, animal health, and human reproductive medicine markets on a global basis. Its primary focus is on addressing the critical temperature-controlled supply chain needs of the rapidly growing cell and gene therapy market. Cryoport, Inc. was founded in 1999, is listed on the NASDAQ exchange under the symbol CYRX, and is headquartered in Brentwood, Tennessee.